# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001048477-24-000059
Filing Date
2024-04-09
Accepted
2024-04-09 16:09:17
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | a2024biomarinproxystatemen.htm | DEFA14A | 9960
2 | GRAPHIC | defa1.jpg | GRAPHIC | 961864
3 | GRAPHIC | defa2.jpg | GRAPHIC | 736864
4 | GRAPHIC | logo_biomarin.jpg | GRAPHIC | 98989
| Complete submission text file | 0001048477-24-000059.txt |  | 2485974

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 24832809
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)